ByteDance (Doubao)

Beijing, China [1, 8, 9] All China companies → — Founded 2012 [7, 8, 9]

Biotech / Drug Discovery Clinical AI Platform Healthcare Conglomerate

Family Medicine Hospital Medicine Internal Medicine

Series E (ByteDance as a whole) [7] — $6.11B over 9 rounds (for ByteDance as a whole) [7, 17], with some sources indicating total funding of $9.4B [20, 21]. ByteDance recently secured a $29.6 billion loan for AI development. [27]

Claim this company

Products

Doubao

ByteDance (Doubao)

General Productivity (AI Assistants)

Doubao is a versatile AI assistant from ByteDance, offering broad capabilities for information processing, content generation, and task automation, which can be utilized by physicians for general productivity and administrative support.

Tiered subscription model

See all 1 product →

About ByteDance (Doubao)

ByteDance (Doubao) is a prominent player in the artificial intelligence (AI) arena, particularly known for its AI chatbot, Doubao, which has rapidly become one of China’s most popular AI applications. [1, 14] The company, widely recognized as the parent of TikTok, has significantly pivoted towards an AI-native model, investing heavily in AI research and development. [1, 20] Doubao operates as a comprehensive AI assistant and model ecosystem, offering capabilities such as chat, writing, reasoning, and content generation, including images (via Seedream) and videos (via Seedance). [3, 15] Its international counterpart is known as Dola. [1, 2, 3]

For physicians, ByteDance’s ventures into healthcare AI are particularly relevant. The company is actively pursuing AI-driven drug design, with teams focused on protein structure prediction, molecular conformation analysis, and computational protein design. [23] Their goal is to accelerate drug discovery and make a significant impact on global healthcare. [23] Beyond drug discovery, ByteDance has also invested in offline healthcare, including the acquisition of a Chinese hospital chain and the establishment of a “smart AI hospital” in Beijing, aiming for full-scenario intelligence from pre-examination to follow-up visits through AI-assisted diagnosis and digital medical record management. [28] They also offer the Xiaohe AI Doctor app for online consultations and health management. [28]

Focus Areas

AI chatbot (Doubao/Dola) generative AI models (Seed Seedance for video Seedream for image) AI for drug design AI for science (biology physics materials molecular dynamics) AI-assisted diagnosis intelligent diagnosis and treatment decision-making digital medical record management enterprise productivity (office tools software development data analysis design workflow automation financial analysis scientific research) content recommendation systems and cloud services (Volcano Engine). [1 2 3 15 18 23 26 28]

Business Intelligence

Key Investors	Susquehanna International Group, Primavera Capital Group, Kohlberg Kravis Roberts, SoftBank Group, Sequoia Capital, General Atlantic, Hillhouse Capital Group, BlackRock, Tiger Global, Temasek, G42, Coatue Management, HongShan
Partnerships	BeiGene (for Center for Oncology Prevention and Clinical Translation), Zhejiang University, Qualcomm, Seres
Acquisitions	musical.ly (2017), News Republic (2017), Pico (2021), Moonton (2021, sold in 2026), AmCare (2022), oladance (2024), Hipacloud (2022)
Technology	Cloud infrastructure, advanced AI algorithms, machine learning capabilities, content recommendation systems, data analytics platforms, generative AI models (Seed 2.0, Seedance 2.0/2.5, Seedream 4.0, Seed-Music, AnewSampling, AnewOmni)

What Physicians Need to Know

AI Chatbot (Doubao/Dola)

Doubao is ByteDance's flagship conversational AI platform, powered by its large language model (LLM) and designed primarily for the Chinese market, though Dola is its international version. It supports multimodal processing (text, images, audio, and upcoming text-to-video generation) and excels in Chinese language capabilities, including idioms, cultural references, internet slang, and technical terminology. Doubao integrates seamlessly with other ByteDance products like Douyin (TikTok), CapCut, Xigua Video, and Feishu, enhancing user experiences and offering AI assistance for content creation and work tasks. It utilizes a Mixture-of-Experts (MoE) design for efficiency and runs on ByteDance's Volcano Engine cloud platform, leveraging Nvidia H800/H20 GPUs and Huawei Ascend chips. Doubao offers an aggressive freemium model, with very low API pricing for businesses and developers, making advanced AI accessible. [1, 2, 10, 13, 19]

Generative AI Models (Seed, Seedance for video, Seedream for image)

ByteDance's generative AI models, built on the Seed series, automatically create new content from text, images, video, and audio inputs. The Doubao series integrates with Seed for multimodal processing. Seedance 2.0 specializes in video generation, offering 'director-level' control precision, dynamic effects, and consistent multi-angle shots, enabling one-click video creation from images or text. Seedream focuses on image generation, and Seed-TTS handles voice synthesis. These models are trained on vast datasets from platforms like TikTok and Douyin, ensuring high-quality outputs. ByteDance also has BAGEL, an open-source, unified multimodal model capable of text and image understanding, text-to-image generation, and intelligent image editing. [1, 10, 11, 14, 25, 36]

AI for Drug Design

ByteDance's drug discovery unit, Anew Labs (also known as Anew Therapeutics or ByteDance AI Drug Discovery), is actively developing AI-designed therapies. They have presented generative AI-designed small molecules targeting proteins previously considered 'undruggable,' such as IL-17 for autoimmune diseases. Anew Labs has released AnewOmni, a generative framework trained on 5 million biomolecular complexes, aiming to design functional molecules across all scales. Their technical outputs include molecular structure prediction models like Protenix and Seedfold, and protein design tools like PXDesign. Anew Labs leverages ByteDance's AI infrastructure and computing power from Volcano Engine, and is in the process of spinning off to secure independent financing. [9, 12, 16, 17, 18, 28]

AI for Science (Biology, Physics, Materials, Molecular Dynamics)

The Seed-AI for Science team at ByteDance applies AI to drive breakthroughs in scientific computing. Their focus areas include multimodal biological foundation models for the design, conformation generation, and structure prediction of biological molecules (proteins, DNA, RNA, small molecules, ions, post-translational modifications), with the goal of creating the open-source Protenix model series. They also conduct interdisciplinary research in machine learning, quantum physics, and quantum chemistry for large-scale, high-precision numerical simulations. Additionally, they explore machine learning techniques in force field development, molecular dynamics simulations (e.g., BAMBOO for lithium battery electrolytes), and enhanced sampling to advance drug and material discovery. [15, 16, 18, 33, 34, 35, 37]

AI-Assisted Diagnosis, Intelligent Diagnosis and Treatment Decision-Making

While specific public details on ByteDance's direct AI-assisted diagnosis and intelligent diagnosis and treatment decision-making products are limited, their extensive work in AI for drug design and AI for science, particularly in biology and molecular dynamics, suggests a strong foundational capability for future applications in this domain. Their focus on understanding biomolecular structures and behaviors could be highly relevant for diagnostic and treatment advancements. [9, 12, 15, 16, 18, 33]

Digital Medical Record Management

There is no specific public information available regarding ByteDance's specialization in digital medical record management. Their enterprise productivity tools, such as Feishu (Lark), offer cloud documents and databases, which could potentially be adapted for secure medical record management, but no dedicated medical record product has been highlighted. [27]

Enterprise Productivity (Office Tools, Software Development, Data Analysis, Design, Workflow Automation, Financial Analysis, Scientific Research)

ByteDance offers enterprise productivity solutions primarily through Feishu (Lark) and its integration with Doubao and Volcano Engine. Feishu provides a comprehensive workplace platform with messaging, video meetings, cloud documents, databases, and workflow tools. ByteDance is integrating Doubao's AI capabilities into these tools for workplace productivity. For software development, they have TRAE, an AI-native coding IDE that integrates Seed Code models for agentic coding workflows. Volcano Engine provides the underlying cloud infrastructure and AI model APIs for enterprises, supporting data analysis, design, workflow automation, and scientific research through its MLOps/LLM platform, Volcano Ark. [3, 4, 27]

Content Recommendation Systems

ByteDance is a pioneer in recommendation systems, which power its flagship platforms like TikTok and Douyin. Their Monolith system is an industrial-scale, real-time recommender system that underpins BytePlus Recommend, enabling rapid personalization. These systems use deep learning models to analyze user behavior (watch time, likes, comments, shares) and content (NLP, image recognition) to deliver highly personalized content. They employ a two-stage approach (candidate generation and ranking) and utilize proprietary algorithms like Deep Reinforcement Learning and Deep Retrieval for efficient, large-scale recommendations. ByteDance's recommendation systems are designed for continuous learning and real-time feedback. [4, 6, 21, 22, 23, 26, 31, 32]

Cloud Services (Volcano Engine)

Volcano Engine is ByteDance's cloud computing and AI service platform, providing enterprise clients with advanced technologies like recommendation algorithms, data analytics, and AI solutions. It offers compute, storage, GPU clusters (including Nvidia H200 chips), databases, CDN, and AI model APIs through Volcano Ark, its MLOps/LLM platform. Volcano Engine emphasizes AI-driven capabilities, including large language models (Doubao family) and multimodal AI services, and has rebuilt its AI data infrastructure around Lance for faster training and production-scale agent memory. It holds a significant market share in China's public cloud MaaS market due to its aggressive low-price strategy and integration with ByteDance's internal ecosystem. [1, 3, 5, 7, 8, 10, 11, 20, 27]

Physician Tip

For physicians, ByteDance's advancements in AI for drug design and AI for science (biology, physics, materials, molecular dynamics) are particularly noteworthy. Their Anew Labs unit is actively developing AI-designed therapies, including small molecules for 'undruggable' targets, which could lead to novel treatments for autoimmune diseases and other conditions. The Seed-AI for Science team's work on multimodal biological foundation models and molecular dynamics simulations could contribute to a deeper understanding of diseases at a molecular level, potentially aiding in diagnostics and personalized medicine in the future. While direct AI-assisted diagnosis and digital medical record management products are not prominently highlighted, the underlying AI capabilities and cloud infrastructure (Volcano Engine) could form the basis for future healthcare solutions. Physicians should monitor ByteDance's progress in these scientific AI domains for potential breakthroughs that could impact clinical practice and drug development.

ByteDance's AI products, particularly Doubao, are deeply integrated within the ByteDance ecosystem (Douyin, TikTok, CapCut, Feishu). For enterprise clients, Volcano Engine serves as the primary platform for accessing Doubao models and other AI capabilities through APIs. This vertical integration across their AI technology stack, from foundational models to application layers, allows for cost efficiency and technological superiority. The company is also making efforts to integrate its enterprise productivity tools like Feishu with Doubao's AI capabilities for enhanced workplace solutions.

At a glance

Founded 2012 [7, 8, 9]

HQ Beijing, China [1, 8, 9] · China

Team size Approximately 120,000 (as of 2025) [9], with 47,593 as of March 31, 2026 [7]. The core AI team for Doubao has seen increased equity incentives. [33]

CEO Liang Rubo [1, 4, 8]

Funding Series E (ByteDance as a whole) [7] — $6.11B over 9 rounds (for ByteDance as a whole) [7, 17], with some sources indicating total funding of $9.4B [20, 21]. ByteDance recently secured a $29.6 billion loan for AI development. [27]

Products 1

Products by ByteDance (Doubao)

1 product in the directory

Doubao

ByteDance (Doubao)

General Productivity (AI Assistants)

Tiered subscription model

What the Web Says

ByteDance's Doubao is a prominent AI assistant, particularly strong in Chinese-language processing, offering a generous free tier and competitive pricing for its paid features. As an employer, ByteDance is known for competitive salaries and benefits, a collaborative environment, and opportunities for learning and growth. However, it is also frequently cited for demanding workloads and work-life balance challenges.nnDoubao has garnered significant attention in China, with 345 million monthly users, and is integrated into the ByteDance ecosystem. While its English output is considered good for everyday tasks, it may lag behind Western counterparts like Claude and ChatGPT for complex reasoning, coding, and nuanced tone. The company has also faced some criticism regarding its hiring process and management in certain departments.

Overall: Mixed

Strengths

Strong Chinese-language processing capabilities for Doubao.
Generous free tier and competitive pricing for Doubao.
Competitive salaries and benefits at ByteDance.
Collaborative work environment and opportunities for learning and growth.
Doubao offers advanced features like image generation, voice input, and document Q&A.
Doubao's mobile app is fast and well-designed.

Limitations

Demanding workload and poor work-life balance at ByteDance.
English output for Doubao lags behind some Western AI assistants for complex tasks.
Privacy concerns due to data processing under Chinese jurisdiction.
Language barrier for non-Mandarin speakers within the company.
Some negative experiences with management and hiring processes.
Doubao's character-making feature was discontinued.

Based on reviews from: Indeed.com, ToolCenter, KidsAiTools, SourceForge, EvoLink.AI, GPT Proto, Reddit, APKPure, The Edge Singapore, Counterpoint Research, Facebook, Wikipedia, Future Stack Reviews

Last updated: 2026-09-08

Videos

News, demos, and interviews about ByteDance (Doubao).

Loading videos...

Videos load interactively. If none appear, search YouTube for ByteDance (Doubao) →

View all on YouTube

Press & Coverage

South China Morning Post

ByteDance's drug unit presents AI-designed therapies at global conferences

ByteDance's drug discovery unit, Anew Labs (also known as Anew Therapeutics or ByteDance AI Drug Discovery), is presenting its AI-designed therapies at international conferences, with teams operating from Shanghai, Singapore, and San Jose, California.

2026-05

Binance News (via Binance Square)

ByteDance Launches Doubao 2.1Pro and Reorients AI Strategy Toward Enterprise Services

ByteDance launched Doubao 2.1Pro, the latest version of its large language model, at the 2026 Volcano Engine Force conference, signaling a pivot in its AI strategy towards enterprise services.

2026-06

Global Times

ByteDance launches paid Doubao Pro plans with AI agent capabilities

ByteDance's Doubao introduced a professional subscription tier based on its Doubao 2.1 AI models, offering paid plans with AI agent capabilities and higher usage limits as a step towards commercialization.

2026-06

The Economic Times

China's ByteDance releases Doubao 2.0 AI model for 'agent era'

ByteDance rolled out its Doubao 2.0 model, an upgrade to China's most widely used AI app, positioning it for the 'agent era' where AI models execute complex real-world tasks.

2026-02

TechRepublic

TikTok Owner ByteDance Targets 2026 Doubao AI Phone Relaunch

ByteDance is preparing to relaunch its Doubao AI smartphone in mid-to-late Q2 2026, after its first-generation device faced challenges, with ZTE's Nubia brand handling the hardware and ByteDance providing the Doubao AI software.

2026-02

South China Morning Post

Why ByteDance and Alibaba are disabling AI agents in China

ByteDance's Doubao and Alibaba's Qwen are disabling customized AI agent features in China due to new Beijing regulations on humanlike AI interaction services, which took effect in July 2026.

2026-07

TNW

ByteDance quietly makes $4bn a year from AI. It just broke up an app to make more.

ByteDance is reportedly making $4 billion a year from AI and is restructuring its workplace app, Lark, by integrating its product team into the Doubao chatbot group and its sales and support staff into its cloud business, Volcano Engine, to enhance its AI capabilities.

2026-07

The Star

ByteDance joins AI elite in race to perfect world models

ByteDance is developing an AI model for real-time spatial video generation, overseen by founder Zhang Yiming, aiming to compete with Meta and Apple in virtual and mixed reality, and has secured a $30 billion loan to expand its AI capabilities.

2026-09

Frequently Asked Questions

What specific AI products does ByteDance offer for healthcare providers and administrators?

ByteDance is heavily investing in AI for healthcare, including an AI-powered hospital in Beijing that integrates AI-assisted diagnosis, intelligent treatment decision-making, and digital medical record management. They also offer the Xiaohe AI Doctor app as a health assistant. [8, 9, 15]

How does ByteDance's generative AI (Seed, Seedance, Seedream) apply to healthcare?

While the direct application of Seed, Seedance (video), and Seedream (image) to healthcare isn't explicitly detailed, ByteDance's AI for Science group focuses on biology, physics, and materials, which are foundational for drug design and other scientific breakthroughs. Their drug discovery unit, Anew Labs, utilizes generative AI to design therapies. [2, 4, 6]

What is ByteDance's involvement in AI for drug design and scientific research?

ByteDance has a dedicated AI drug discovery unit, Anew Labs (also known as Anew Therapeutics or ByteDance AI Drug Discovery), which is showcasing AI-designed therapies at international scientific conferences. They have developed molecular structure prediction models like Protenix and Seedfold, and a protein binder design tool called PXDesign. [1, 2, 3, 4, 5]

What are the pricing and support models for ByteDance's healthcare AI solutions like Doubao/Dola?

Doubao offers a tiered subscription model with a free version for basic features and paid plans for professional productivity scenarios, such as software development and data analysis. The standard plan costs 68 yuan ($10) per month, with enhanced and premium plans at 200 yuan and 500 yuan respectively. [18, 23, 25, 26]

What are ByteDance's partnerships and compliance strategies within the healthcare sector, especially concerning data privacy and security?

ByteDance has made significant investments in physical healthcare facilities and online health platforms, including the acquisition of Amcare Healthcare and Baikemy.com. [7, 8, 10, 11, 14, 16, 17, 19, 21, 22] While the company is expanding its healthcare footprint, specific details on compliance strategies and data privacy frameworks for healthcare data were not extensively detailed in the provided information, though they did settle a US lawsuit regarding children's privacy with TikTok. [28]

Related Companies

Suggest an Edit →